The Food and Drug Administration and the National Cancer Institute announced plans to strengthen their joint efforts in cancer treatment and prevention and create new collaborative programs. Areas of collaboration will include developing "biomarkers" to evaluate medicines' effectiveness, creating a cancer information infrastructure to improve data collection and analyses, and advancing the development and evaluation of cancer preventatives. The agencies also plan to improve consumer awareness of the consequences of diet and nutrition on cancer prevention. -- by Cinda Becker
FDA, cancer institute to increase collaboration
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.